麻豆传媒

More patients taking sodium zirconium cyclosilicate achieved normokalemia vs placebo recipients

Benefit shown in trial of patients flagged for high risk of cardiotoxicity

Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts

No excess infections when pacemakers were cleaned and repackaged for resource-deprived patients

Phase II trial does hold a few signals that might warrant another attempt

Most are eligible for weight management indication

Phase I results show "big improvement" for what is usually progressive hypertrophy, expert says

A cardiovascular-focused letter led to larger improvements in vaccine uptake in Danish program

Procedure also noninferior to anticoagulation for death, stroke, or systemic embolism composite

AI transformation of the way cardiology uses echo "is absolutely going to happen, expert says

Drug discontinuations may have leveled any benefit in CLEAR OASIS 9 trial

Japanese trial supports use but event risk might be low enough to suggest a different strategy

Microemboli now questioned as driver of cognitive impairment in atrial fibrillation

One-time treatment with nexiguran ziclumeran tied to decline in serum TTR levels in phase I trial